Aligos Therapeutics (ALGS) Cash from Financing Activities (2019 - 2026)
Aligos Therapeutics (ALGS) reported Cash from Financing Activities of $220,000 for Q2 2026, compared with -$177,000 a year earlier.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aligos Therapeutics' Cash from Financing Activities came in at $228,000, down 99.8% year-over-year; for FY2025, it came in at $101.64 million.
- Cash from Financing Activities has a five-year compound annual growth rate of -12.0% (FY2020 to FY2025).
- By year, Cash from Financing Activities came in at $355,000 in FY2024 (-99.6%), $88.33 million in FY2023, $164,000 in FY2022 (-99.8%) and $78.68 million in FY2021 (-59.1%).
- The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities since Q1 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$62,000 (Q1 2026), $123,000 (Q4 2025) and -$53,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | 220,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220,000.00 |
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -177,000.00 |
| Mar 31, 2025 | 101.74 Mn |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | 281,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | 87.94 Mn |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 414,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | -19,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | -21,000.00 |
| Dec 31, 2021 | 552,000.00 |
| Sep 30, 2021 | 77.95 Mn |
API Access
Aligos Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();